Navigation Links
AVI BioPharma Partner Cook Medical Announces Completion of Patient,Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of,Cardiovascular Disease

PORTLAND, Ore.--(BUSINESS WIRE)--Jul 10, 2007 - AVI BioPharma, Inc. (Nasdaq:AVII) announced today that its partner Cook Medical has completed target patient enrollment and released six-month follow-up data from a Phase II clinical trial known as Appraisal. The trial, currently being held in Germany, was designed to study the effect of the Neugene(R) antisense drug Resten-MP(TM), when used in conjunction with the placement of one or more bare metal stents, in the prevention of cardiovascular restenosis, the narrowing of an artery following a cardiac procedure such as angioplasty.

"We are pleased with the progress our partner Cook Medical has made with our NEUGENE in this trial," said K. Michael Forrest, interim chief executive officer of AVI. "We look forward to continuing our collaboration with Cook Medical as they work to commercialize our technology in the cardiology market."

Cook's release may be viewed on AVI's website at www.avibio.com.

About AVI BioPharma

AVI BioPharma develops therapeutic products for the treatment of life-threatening diseases using third-generation NEUGENE antisense drugs and ESPRIT exon skipping technology. AVI's lead NEUGENE antisense compound is designed to target cell proliferation disorders, including cardiovascular restenosis. In addition to targeting specific genes in the body, AVI's antiviral program uses NEUGENE antisense compounds to combat disease by targeting single-stranded RNA viruses, including West Nile virus, hepatitis C virus, dengue virus, Ebola virus and influenza A virus. AVI's NEUGENE-based ESPRIT technology will initially be applied to potential treatments for Duchenne muscular dystrophy. More information about AVI is available on the company's Web site at http://www.avibio.com.

About Cook Medical

Cook Medical was the first company to introduce interventional devices in the United States. Today, the company participates in all gl
'"/>




Page: 1 2

Related medicine technology :

1. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
2. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
3. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
4. Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory Drugs
5. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
6. AVI BioPharma Reports Positive Pre-Clinical Influenza Data
7. Helix BioPharma Corp. Announces Positive Phase II Clinical Results with its Topical Interferon Alpha-2b
8. CeNeRx BioPharma Announces Positive Phase I Results in First Human Trial of Third Generation RIMA Antidepressant
9. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
10. GenoLogics Announces Bioinformatics Partnership with Illumina
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care

Post Your Comments:
(Date:11/20/2009)... -- ,, Reportlinker.com announces that a new ma.... ,, Global Markets for Breast Biopsy Devices .../Global-Markets-for-Breast-Biopsy-Devices-2009.htm...campaign=prnewswire ,, The global markets for...core needle market and vacuum assisted breast biop...
(Date:11/20/2009)... Boston Scientific Corpo...received 510(k) clearance from the U.S. Food and D...arket its WallFlex® Fully Covered Esophageal ...rictures (obstructions) caused by tumors in patien...ncer. ,, (Photo: http://www.newscom.com/cgi-...
(Date:11/20/2009)...PRNewswire-USNewswire/ -- In response to a recent ...tly available medications designed to treat and pr...te, an independent nonprofit organization, is offe... Prevention of Prostate Cancer for free download...rticle, " Drugs to Deter Some Cancers Are Not Take...
Breaking Medicine Technology:Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3CMHS 28dba Hybrid Energy Holdings 29 changes name of corporation and prepares to file for ticker symbol change with FINRA 58135 1CMHS 28dba Hybrid Energy Holdings 29 changes name of corporation and prepares to file for ticker symbol change with FINRA 58135 2Bubble Trouble Team Hits the Lab for Good Hygiene 58133 1Bubble Trouble Team Hits the Lab for Good Hygiene 58133 2Bubble Trouble Team Hits the Lab for Good Hygiene 58133 3Bubble Trouble Team Hits the Lab for Good Hygiene 58133 4MedShape Solutions Inc Announces First FDA cleared Shape Memory PEEK Device 3B Closing of 2410M Equity Offering 14230 1MedShape Solutions Inc Announces First FDA cleared Shape Memory PEEK Device 3B Closing of 2410M Equity Offering 14230 2
...irstCall/ -- Auxilium,Pharmaceuticals, Inc. today ...oms of decreased libido, energy levels and,erectil...switching,brands of testosterone replacement gel t...icantly in patients who switched to,Auxilium,s Tes...response to Solvay S.A.,s Androgel(R) (testosteron...
...College of Cardiology,s,Board of Trustees has appr....C., arising from his statements that resulted in ... embargo on the,COURAGE trial data presented at Am...cientific Session in March. ,The Board accepted th...pline Committee to issue a letter of censure to an...
Other Medicine Technology:Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 2Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 3Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 4Auxilium Announces New Data That Show Total Testosterone Blood,Levels Increase Significantly Following Switch from AndroGel(R) to,Testim(R) 5
(Date:11/20/2009)...., Nov. 20 Rates of infe...aked in late October, but the pandemic flu virus c...l age groups, including the elderly, according to ...SE: DGX ), the world,s leading provider of diagn... its most recent Quest Diagnostics Health Trends(T...
(Date:11/20/2009)...20 The following is a s...he Nevada Health Care Association: ,, "The Neva...nks Senate Majority Leader Harry Reid for his lead...ur goal of protecting every Nevada seniors, ongoin...ing the strength and viability of our state,s vita...
(Date:11/20/2009)...vember 20, 2009Emergency medical service (EMS) pro...0,000 cardiac arrests each year. Only 5 to 10 per...ive. Better quality cardiopulmonary resuscitation...e associated with better patient outcome. The Res...t clinical research network to study prehospital t...
(Date:11/20/2009)...high and is expected to continue, CDC says, , ...areas of the United States are seeing declines in ... said Friday, and while the disease remains widesp...reported last week. , "We are beginning to see ...ntry, but there is still a lot of influenza everyw...
(Date:11/20/2009)... ANGELES, Nov. 20 California minor...ican Families, The Wall/Las Memorias, Latina Breas...Program, and the Real Medicine Foundation today se...n the company to reconsider harmful and discrimina...hield specifically calls for an end to the practic...
Breaking Medicine News(10 mins):Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Swine Flu Declining in Some Parts of U.S. 2Health News:Swine Flu Declining in Some Parts of U.S. 3Health News:California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pain Access to Proper Medication 2Health News:California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pain Access to Proper Medication 3Health News:California Minority Advocacy Groups Send Letter to Blue Shield of California Calling for an End to Discriminatory Practice that Denies Patients in Pain Access to Proper Medication 4
...tage of services in a hospital at Brisbane a patie...y. Although he was attacked and was in serious con...al in question is // the Caboolture Hospital, wher... day. The statement by a spokesman for the Que...
... largest drug maker, Pfizer has announced that it ...in India. Exubera received regulatory approvals fr... European Commission last week. The drug has been ...syringes are needed. "Until today, patients with d...
..., a Crohn’s patient has successfully reached the V...ountains. The climb began // on January 12th and w...ght days of unpredictable and sub-freezing tempera...ost 80 pounds and his large intestine through an o...
...reet Journal studied about the effects of stress o...ber of researches is being conducted on stress and... There is an increase in the number of pregnant...ement of stress during pregnancy. Women es...
...rds in Cyprus are reported to be infected with the...the virus in a European Union country, even though...ts of the island. // Northern Cyprus where the inf...asualties in Turkey. Animal products imports from ...
... certification has been received by the global hea...cting the Neissera gonorrhoeae (NG) and Chlamydia .... This will enable the company to sell the product...article technology. Where sexually transmit...
Other Medicine News:Health News:Crohn's Patient Robert Hill’s greatest achievemen 2
... Roches patented polymerase chain reaction (PCR) t...cation technology, is an essential component of Ro...roducts. PCR allows minute amounts of selected uni...to billions of copies (that is, to detectable leve...
BenchMark® XT
... Reicherts new ATP Auto Non-Contact Tonometer / Pa... pachymeter, combining the measurement of IOP and ...e to numerous clinical studies that have shown the... as well as intraocular pressure in the management...
... Argent Global Services is a process engineering a...development and implementation of productivity imp...tegies. Argent utilizes industrial engineering, le... significant and cost effective solutions that dri...
Medicine Products: